MedPath

广西南宁邕江药业有限公司

Ownership
-
Established
2000-10-09
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

14

NMPA:14

Drug Approvals

Ofloxacin Injection

Product Name
氧氟沙星注射液
Approval Number
国药准字H20045063
Approval Date
Sep 26, 2020
NMPA

Citicoline Sodium Injection

Product Name
胞磷胆碱钠注射液
Approval Number
国药准字H20045052
Approval Date
Sep 26, 2020
NMPA

Lysine Hydrochloride Injection

Product Name
镇通
Approval Number
国药准字H20000554
Approval Date
Sep 26, 2020
NMPA

Azithromycin Dispersible Tablets

Product Name
阿奇霉素分散片
Approval Number
国药准字H10980171
Approval Date
Sep 20, 2020
NMPA

Promethazine Hydrochloride Tablets

Product Name
盐酸异丙嗪片
Approval Number
国药准字H45020584
Approval Date
Sep 20, 2020
NMPA

Lisinopril Capsules

Product Name
赖诺普利胶囊
Approval Number
国药准字H19990311
Approval Date
Sep 20, 2020
NMPA

Compound Lysine Granules

Product Name
复方赖氨酸颗粒
Approval Number
国药准字H20013337
Approval Date
Sep 20, 2020
NMPA

Roxithromycin Capsules

Product Name
罗红霉素胶囊
Approval Number
国药准字H10980172
Approval Date
Sep 20, 2020
NMPA

Promethazine Hydrochloride Tablets

Product Name
盐酸异丙嗪片
Approval Number
国药准字H45020520
Approval Date
Sep 20, 2020
NMPA

Lysine Hydrochloride Granules

Product Name
L-赖氨酸盐酸盐颗粒
Approval Number
国药准字H19999091
Approval Date
Sep 20, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.